2H-1,5-Benzodioxepin-2-carboxylic acid, 3,4-dihydro-3-hydroxy-(33632-66-5)
- Name: 2H-1,5-Benzodioxepin-2-carboxylic acid, 3,4-dihydro-3-hydroxy-
- Synonyms:2H-1,5-Benzodioxepin-2-carboxylic acid, 3,4-dihydro-3-hydroxy-
- Molecular Formula:C10H10 O5
- Molecular Weight:210.186
- CAS Registry Number:33632-66-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.33632-66-5 2H-1,5-Benzodioxepin-2-carboxylic acid,3,4-dihydro-3-hydroxy-
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
Other Product
- 228115-57-9/.beta.-D-Galactopyranose, 1,6-anhydro-, 4-acetate 2-(diphenyl phosphate)
- 228115-56-8/.beta.-D-Galactopyranose, 1,6-anhydro-, 3,4-diacetate 2-(diphenyl phosphate)
- 228115-55-7/.beta.-D-Galactopyranose, 1,6-anhydro-, 2-bis(phenylmethyl) phosphate
- 228115-54-6/.beta.-D-Galactopyranose, 1,6-anhydro-, 2-(diphenyl phosphate)
- 228115-53-5/.beta.-D-Galactopyranose, 1,6-dideoxy-1,6-epithio-3,4-O-(1-methylethylidene)-, bis(phenylmethyl) phosphate
- 228115-52-4/.beta.-D-Galactopyranose, 1,6-anhydro-3,4-O-(1-methylethylidene)-, bis(phenylmethyl) phosphate
- 228115-51-3/.beta.-D-Galactopyranose, 1,6-anhydro-3,4-O-(1-methylethylidene)-, diphenyl phosphate
- 228115-50-2/.beta.-D-Galactopyranose, 1,6-dideoxy-1,6-epithio-3,4-O-(1-methylethylidene)-
- 228115-49-9/.beta.-D-Gulopyranose, 3-amino-1,6-anhydro-3-deoxy-, 2-(dihydrogen phosphate)
- 228115-48-8/.beta.-D-Gulopyranose, 1,6-anhydro-3-bis(phenylmethyl)amino-3-deoxy-2-O-(1,5-dihydro-3-oxido-2,4,3-benzodioxaphosphepin-3-yl)-, 4-acetate
- 228115-47-7/.beta.-D-Gulopyranose, 1,6-anhydro-3-bis(phenylmethyl)amino-3-deoxy-2-O-(1,5-dihydro-3-oxido-2,4,3-benzodioxaphosphepin-3-yl)-
- 228115-46-6/.beta.-D-Gulopyranose, 1,6-anhydro-3-bis(phenylmethyl)amino-3-deoxy-2-O-(1,5-dihydro-3-oxido-2,4,3-benzodioxaphosphepin-3-yl)-4-O-(tetrahydro-2H-pyran-2-yl)-
- 228115-45-5/.beta.-D-Gulopyranose, 1,6-anhydro-3-bis(phenylmethyl)amino-3-deoxy-4-O-(tetrahydro-2H-pyran-2-yl)-
- 228115-44-4/.beta.-D-Gulopyranose, 1,6-anhydro-3-deoxy-3-(phenylmethyl)amino-4-O-(2R)-tetrahydro-2H-pyran-2-yl-
- 228115-43-3/4,7-Epoxyoxepino4,3-doxazol-2(1H)-one, hexahydro-1-(phenylmethyl)-8-(tetrahydro-2H-pyran-2-yl)oxy-, (3aR,4R,7R,8R,8aR)-
- 228115-42-2/4,7-Epoxyoxepino4,3-doxazol-2(1H)-one, hexahydro-8-hydroxy-1-(phenylmethyl)-, (3aR,4R,7R,8R,8aR)-
- 228115-41-1/.beta.-D-Gulopyranose, 1,6-anhydro-3-deoxy-3-(1,1-dimethylethoxy)carbonylamino-
- 228115-40-0/.beta.-D-Gulopyranose, 3-amino-1,6-anhydro-3-deoxy-, 4-acetate 2-(dihydrogen phosphate)
- 228113-75-5/Ethanone, 1-[(1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl]- (9CI)
- 33632-66-5/2H-1,5-Benzodioxepin-2-carboxylic acid, 3,4-dihydro-3-hydroxy-
- 228104-62-9/Pyrrolidine, 1-methyl-2-(nitromethylene)-, (2Z)- (9CI)
- 228099-00-1/Pyrrolidine, 1-acetyl-2,4-dimethyl-4-(2-propenyl)- (9CI)
- 228098-99-5/Piperidine, 1-acetyl-2,5,5-trimethyl- (9CI)
- 228098-95-1/4-Cyclohexene-1,2,3-triol,6-methoxy-,(1R,2R,3S,6S)-rel-(9CI)
- 228086-51-9/2-Oxepanemethanol,7-methoxy-(9CI)
- 227963-57-7/ETHYL 3-(2-AMINO-5-BROMOPYRIDIN-3-YL)ACRYLATE
- 227960-58-9/2H-1-BENZOPYRAN-2-CARBOXYLIC ACID, 3,4-DIHYDRO-6-IODO-
- 227959-96-8/1,2-Propadien-1-one,3-[(4-methoxyphenyl)imino]-(9CI)
- 227958-69-2/1,3,4-Thiadiazole-2-carboxylicacid,5-amino-,methylester(9CI)
- 33631-90-2/2H-1,5-Benzodioxepin-2-carboxylic acid, 3,4-dihydro-3-hydroxy-3-methyl-, acetate (8CI)